Neurovascular specialists focus on the intricate relationship between the nervous system and its vascular supply, managing diseases where cerebral blood flow is disrupted. They address critical conditions such as ischemic and hemorrhagic stroke, transient ischemic attacks, cerebral vasculitis, and vascular malformations like aneurysms and AVMs. These experts possess deep knowledge of cerebral circulation and neurovascular anatomy, allowing them to make swift, high-stakes decisions in time-sensitive situations. Using advanced imaging tools such as CT angiography, MR perfusion, and transcranial Doppler, they identify vascular irregularities that may precede serious neurologic damage.
Their expertise is pivotal in guiding acute interventions—whether delivering thrombolytics within the therapeutic window or conducting catheter-based procedures to extract clots or repair ruptured vessels. Neurovascular specialists also play a key role in the post-event phase by monitoring patients for complications like vasospasm, secondary bleeding, or reocclusion. Many are also deeply involved in studying the biological mechanisms of neurovascular coupling and endothelial function, seeking to uncover how systemic conditions like diabetes or atrial fibrillation influence cerebral hemodynamics. By emphasizing early detection and secondary prevention, they help mitigate long-term cognitive and motor impairments. Their work shapes both emergency protocols and long-term care models for vascular brain health.
Title : Perception and individuality in patient cases identifying the ongoing evolution of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Ken Ware, NeuroPhysics Therapy Institute, Australia
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Personalized and Precision Medicine (PPM), as a unique healthcare model through biodesign-driven biotech and biopharma, translational applications, and neurology-related biomarketing to secure human healthcare and biosafety
Sergey Victorovich Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Neuro sensorium
Luiz Moutinho, University of Suffolk, United Kingdom
Title : GBF1 inhibition reduces amyloid-beta levels in viable human postmortem Alzheimer's disease cortical explant and cortical organoid models
Sean J Miller, Yale School of Medicine, United States
Title : Traumatic Spinal Cord Injuries (tSCI) - Are the radiologically based “advances” in the management of the injured spine evidence-based?
W S El Masri, Keele University, United Kingdom